❗ Did you know? Some continuous glucose monitoring devices are cleared by the FDA for use in pregnancy; there are growing data on the use of CGM in the hospital and type 2 diabetes settings. CME 📝 Take our activity here:
Leigh Schmidt, MSN, RN, CNE, CHCPLeigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.This activity has been peer reviewed and the reviewer has no relevant financial relationships.
. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine's Maintenance of Certification program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada members must log into Mainpro+® to claim this activity. Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.Awarded 1.50 contact hour of nursing continuing professional development for RNs and APNs; 0.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US FDA approves BioMarin's gene therapy for hemophilia AThe U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical's gene therapy for severe hemophilia A, the company said, giving patients with the inherited bleeding disorder an alternative to regular injections of missing blood proteins.
Read more »
Merus stock jumps 10% after FDA’s action on cancer drugShares of Merus NV rallied as much as 10% in the extended session Thursday after the pharma company said the U.S. Food and Drug Administration has granted...
Read more »
Gene therapy for severe hemophilia is approved by FDAU.S. health regulators have approved a gene therapy for the most common form of hemophilia
Read more »
FDA OKs Pancreatic Islet Cell Therapy for Type 1 DiabetesApproval of Lantidra, a beta cell therapy derived from donor pancreatic islets, came despite transplant surgeons' concerns about FDA regulating these cells as biologics rather than transplanted organs.
Read more »
FDA approves BioMarin’s gene therapy drug for hemophiliaBioMarin Pharmaceutical Inc. received Food and Drug Administration approval of its gene therapy Roctavian to treat hemophilia A, the agency said late...
Read more »
Gene therapy for severe hemophilia is approved by FDAU.S. officials on Thursday approved drugmaker BioMarin's gene therapy for the most common form of hemophilia, an infused treatment that can significantly reduce dangerous bleeding problems.
Read more »